Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Walmart ventures into mainstream health insurance: Medicare Walmart ventures into mainstream health insurance: Medicare
Blog January 29, 2021
Walmart ventures into mainstream health insurance: Medicare
Molina's hunt to grab small MCOs expands growth into new markets Molina's hunt to grab small MCOs expands growth into new markets
Blog January 25, 2021
Molina's hunt to grab small MCOs expands growth into new markets
Searching for the silver lining: COVID-19 and influenza Searching for the silver lining: COVID-19 and influenza
Blog January 5, 2021
Searching for the silver lining: COVID-19 and influenza
Blog December 22, 2020
Formulary attributes: An influencer of drug access
Medtech product lifecycle Medtech product lifecycle
Blog December 16, 2020
CMS unveils new alternative payment models targeting rural health and therapy areas
Dialog – an IEEE Milestone Award recipient Dialog – an IEEE Milestone Award recipient
Blog December 1, 2020
Dialog – an IEEE Milestone Award recipient
Delays in clinical trials present opportunities for pharma companies to evolve Delays in clinical trials present opportunities for pharma companies to evolve
Blog November 25, 2020
Delays in clinical trials present opportunities for pharma companies to evolve
Pharma research and development - ip in life sciences Pharma research and development - ip in life sciences
Blog November 3, 2020
What’s driving oncology HTAs in South Korea?
Biomarkers have several key roles in clinical trials and precision medicine Biomarkers have several key roles in clinical trials and precision medicine
Blog November 2, 2020
Biomarkers have several key roles in clinical trials and precision medicine
Six U.S. healthcare policy questions hanging in the balance Six U.S. healthcare policy questions hanging in the balance
Blog October 15, 2020
Six U.S. healthcare policy questions hanging in the balance